MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, G.
Right arrow Articles by Aguilera, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, G.
Right arrow Articles by Aguilera, G.

Vol. 59, Issue 3, 485-492, March 2001

Inhibition of Corticotropin Releasing Hormone Type-1 Receptor Translation by an Upstream AUG Triplet in the 5' Untranslated Region

Guoheng Xu, Cristina Rabadan-Diehl, Maria Nikodemova, Peter Wynn,1 Joachim Spiess, and Greti Aguilera

Section on Endocrine Physiology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland (G.X., C.R.-D., M.N., P.W., G.A.); and Max Planck Institute of Experimental Medicine, Göttingen, Germany

The influence of an upstream open reading frame (ORF) in the 5'-untranslated region (UTR) of the mRNA on corticotropin-releasing hormone receptor type 1 (CRHR1) translation was studied in constructs containing the 5'-UTR of CRHR1, with or without an ATG-to-ATA mutation in the upstream ORF, and the main ORF of luciferase or CRHR1. Upstream mutation in luciferase constructs increased luciferase activity when transfected into COS-7 or AtT20 cells compared with the native 5'-UTR. Transfection of CRHR1 constructs containing the upstream mutation into AtT20 or LVIP2.0zc reporter cells, resulted in higher 125I-Tyr-oCRH binding and corticotropin-releasing hormone-stimulated cAMP production, without changes in CRHR1 mRNA levels (measured by RNase protection assay). In vitro translation of luciferase or CRHR constructs with or without mutation of the upstream ATG, and Western blot analysis with anti-luciferase and anti-CRHR1 antibodies confirmed that mutation of the upstream ATG increases translation of the main ORF. The mechanism by which the upstream ORF inhibits translation may involve translation of the upstream peptide, because in vitro translation, or transfection into LVIP2.0zc cells of a fusion construct of the upstream ORF and green fluorescent protein (GFP) yielded a band consistent with the molecular size of GFP protein. The study shows that the upstream AUG in 5'-UTR of CRHR1 mRNA inhibits receptor expression by inhibiting mRNA translation and suggests the short open reading frame in the 5'-UTR plays a role in regulating translation of the CRH receptor.

1 Present address: Department of Animal Science, University of Sydney, Camden, NSW, Australia.

Copyright © 2001 by U.S. Government


This article has been cited by other articles:


Home page
 J Mol EndocrinolHome page
T. Ren, J. He, H. Jiang, L. Zu, S. Pu, X. Guo, and G. Xu
Metformin reduces lipolysis in primary rat adipocytes stimulated by tumor necrosis factor-{alpha} or isoproterenol.
J. Mol. Endocrinol., August 1, 2006; 37(1): 175 - 183.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Kageyama, K. Hanada, T. Moriyama, T. Nigawara, S. Sakihara, and T. Suda
G Protein-Coupled Receptor Kinase 2 Involvement in Desensitization of Corticotropin-Releasing Factor (CRF) Receptor Type 1 by CRF in Murine Corticotrophs
Endocrinology, January 1, 2006; 147(1): 441 - 450.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. T. Weiss, S. L. Lake, E. S. Silverman, E. K. Silverman, B. Richter, J. M. Drazen, and K. G. Tantisira
Asthma Steroid Pharmacogenetics: A Study Strategy to Identify Replicated Treatment Responses
Proceedings of the ATS, December 1, 2004; 1(4): 364 - 367.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
K. G. Tantisira, S. Lake, E. S. Silverman, L. J. Palmer, R. Lazarus, E. K. Silverman, S. B. Liggett, E. W. Gelfand, L. J. Rosenwasser, B. Richter, et al.
Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids
Hum. Mol. Genet., July 1, 2004; 13(13): 1353 - 1359.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
S. Kriaucionis and A. Bird
The major form of MeCP2 has a novel N-terminus generated by alternative splicing
Nucleic Acids Res., March 19, 2004; 32(5): 1818 - 1823.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
C. Rabadan-Diehl, S. Volpi, M. Nikodemova, and G. Aguilera
Translational Regulation of the Vasopressin V1b Receptor Involves an Internal Ribosome Entry Site
Mol. Endocrinol., October 1, 2003; 17(10): 1959 - 1971.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics